Reuters: Supreme court rules against Nestle unit on patent
WASHINGTON |
(Reuters) - The Supreme Court ruled on Tuesday that Prometheus
Laboratories could not patent a diagnostic method to observe changes in a
patient's body to determine the best drug dosage for certain diseases, a
decision that may affect the future of personalized medicine.......
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.